Lantern Pharma (LTRN) Capital Expenditures (2021 - 2025)
Lantern Pharma (LTRN) recorded Capital Expenditures of $1.00 in Q4 2025, down 100.0% from $3,083 a year earlier and down 99.8% from the prior quarter.
Powered by 
Analysis
Lantern Pharma (LTRN) Capital Expenditures (2021 - 2025) Analysis & Trends
For FY2025, Lantern Pharma reported Capital Expenditures of $1,715, down 86.4% from FY2024.
- Annual Capital Expenditures has declined for three straight years, with a four-year compound annual growth rate of -42.3% (FY2021 to FY2025).
- Across earlier years, Capital Expenditures came in at $12,595 in FY2024 (-32.8%), $18,734 in FY2023 (-32.7%), $27,844 in FY2022 (+79.7%) and $15,499 in FY2021.
- Quarterly Capital Expenditures has ranged from $1.00 in Q4 2021 to $8,876 in Q1 2023 over the past five years.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 92.6% in Q3 2022, against a decline of 100.0% in Q4 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Lantern Pharma | 7.95 Mn | -28.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.00 |
| Sep 30, 2025 | 555.00 |
| Mar 31, 2025 | 1,159.00 |
| Dec 31, 2024 | 3,083.00 |
| Sep 30, 2024 | 3,028.00 |
| Jun 30, 2024 | 4,267.00 |
| Mar 31, 2024 | 2,217.00 |
| Dec 31, 2023 | 5,081.00 |
| Sep 30, 2023 | 4,777.00 |
| Mar 31, 2023 | 8,876.00 |
| Dec 31, 2022 | 6,955.00 |
| Sep 30, 2022 | 6,711.00 |
| Dec 31, 2021 | 1.00 |
| Sep 30, 2021 | 3,484.00 |
API Access
Lantern Pharma Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=LTRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "LTRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=LTRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();